BACKGROUND: Lowering the dietary glycemic load and increasing protein intake may be advantageous for weight management. OBJECTIVE: This randomized controlled trial was designed to evaluate the effects of an ad libitum reduced-glycemic-load (RGL) diet on body weight, body composition, and cardiovascular disease (CVD) risk markers in overweight and obese adults during an initial weight-loss phase (12 wk) and a weight-loss maintenance phase (weeks 24-36). DESIGN: Subjects were assigned to RGL (n = 43) or low-fat, portion-controlled (control; n = 43) diet groups. The RGL group was instructed to eat until satisfied, maintaining a low carbohydrate intake during weeks 0-2 and adding low-glycemic-index carbohydrate thereafter. Control subjects were instructed to reduce fat intake and decrease portion sizes, with a targeted energy deficit of 500 to 800 kcal/d. RESULTS: The RGL group had lost significantly more weight than did the control group at week 12 (-4.9 and -2.5 kg, respectively; P = 0.002), but the 2 groups did not differ significantly at week 36 (-4.5 and -2.6 kg, respectively; P = 0.085). Changes in fat mass differed between the groups at week 12 (-1.9 and -0.9 kg, respectively; P = 0.016) but not at week 36 (-2.0 and -1.3 kg, respectively; P = 0.333). At the end of the study, no differences were found in responses for CVD risk markers except a larger mean change in HDL cholesterol in the RGL group than in the control group (3.8 and 1.9 mg/dL, respectively; P = 0.037). CONCLUSION: These findings provide evidence that an ad libitum RGL diet is a reasonable alternative to a low-fat, portion-controlled eating plan for weight management.
RCT Entities:
BACKGROUND: Lowering the dietary glycemic load and increasing protein intake may be advantageous for weight management. OBJECTIVE: This randomized controlled trial was designed to evaluate the effects of an ad libitum reduced-glycemic-load (RGL) diet on body weight, body composition, and cardiovascular disease (CVD) risk markers in overweight and obese adults during an initial weight-loss phase (12 wk) and a weight-loss maintenance phase (weeks 24-36). DESIGN: Subjects were assigned to RGL (n = 43) or low-fat, portion-controlled (control; n = 43) diet groups. The RGL group was instructed to eat until satisfied, maintaining a low carbohydrate intake during weeks 0-2 and adding low-glycemic-index carbohydrate thereafter. Control subjects were instructed to reduce fat intake and decrease portion sizes, with a targeted energy deficit of 500 to 800 kcal/d. RESULTS: The RGL group had lost significantly more weight than did the control group at week 12 (-4.9 and -2.5 kg, respectively; P = 0.002), but the 2 groups did not differ significantly at week 36 (-4.5 and -2.6 kg, respectively; P = 0.085). Changes in fat mass differed between the groups at week 12 (-1.9 and -0.9 kg, respectively; P = 0.016) but not at week 36 (-2.0 and -1.3 kg, respectively; P = 0.333). At the end of the study, no differences were found in responses for CVD risk markers except a larger mean change in HDL cholesterol in the RGL group than in the control group (3.8 and 1.9 mg/dL, respectively; P = 0.037). CONCLUSION: These findings provide evidence that an ad libitum RGL diet is a reasonable alternative to a low-fat, portion-controlled eating plan for weight management.
Authors: E E Blaak; J-M Antoine; D Benton; I Björck; L Bozzetto; F Brouns; M Diamant; L Dye; T Hulshof; J J Holst; D J Lamport; M Laville; C L Lawton; A Meheust; A Nilson; S Normand; A A Rivellese; S Theis; S S Torekov; S Vinoy Journal: Obes Rev Date: 2012-07-11 Impact factor: 9.213
Authors: Zhiying Zhang; Elaine Lanza; Penny M Kris-Etherton; Nancy H Colburn; Deborah Bagshaw; Michael J Rovine; Jan S Ulbrecht; Gerd Bobe; Robert S Chapkin; Terryl J Hartman Journal: Lipids Date: 2010-08-24 Impact factor: 1.880
Authors: Sai Krupa Das; Cheryl H Gilhooly; Julie K Golden; Anastassios G Pittas; Paul J Fuss; Gerard E Dallal; Megan A McCrory; Edward Saltzman; Susan B Roberts Journal: Open Nutr J Date: 2007-04-01
Authors: M Rossi; F Turati; P Lagiou; D Trichopoulos; L S Augustin; C La Vecchia; A Trichopoulou Journal: Diabetologia Date: 2013-08-22 Impact factor: 10.122
Authors: Kelly B Scribner; Dorota B Pawlak; Cristin M Aubin; Joseph A Majzoub; David S Ludwig Journal: Am J Physiol Endocrinol Metab Date: 2008-09-09 Impact factor: 4.310
Authors: Shelley Kirk; Bonnie Brehm; Brian E Saelens; Jessica G Woo; Elizabeth Kissel; David D'Alessio; Christopher Bolling; Stephen R Daniels Journal: J Pediatr Date: 2012-02-28 Impact factor: 4.406
Authors: James M Shikany; Lesley F Tinker; Marian L Neuhouser; Yunsheng Ma; Ruth E Patterson; Lawrence S Phillips; Simin Liu; David T Redden Journal: Nutrition Date: 2010-01-06 Impact factor: 4.008